Menu Close

Oragenics Inc.’s (AMEX:OGEN) Stock Is Down -5.35%, But Is It Capable Of A Rally?

view original post

Oragenics Inc. (AMEX:OGEN) traded at $0.50 at last check on Monday, January 10, made a downward move of -5.35% on its previous day’s price.

Looking at the stock we see that its previous close was $0.52 and the beta (5Y monthly) reads 0.10 with the day’s price range being $0.50 – $0.54. In terms of its 52-week price range, OGEN has a high of $1.80 and a low of $0.43. The company’s stock has gained about 5.80% over that past 30 days.


3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Oragenics Inc. has a market cap of $61.16 million and is expected to release its quarterly earnings report on Aug 16, 2021. Estimates by analysts give the company expected earnings per share (EPS) of -$0.04, with the EPS growth for the year raised at -$0.16 for 2021 and -$0.18 for next year. These figures represent 66.00% and -12.50% growth in EPS for the two years respectively.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the OGEN stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Oragenics Inc. (OGEN) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 2.18% off its SMA20 and -8.52% from its 50-day simple moving average. The RSI (14) is pointing at 48.45 while the volatility over the past week is 10.48% and jumps to 8.93% over the past one month. The beta value is -0.01, while the average true range (ATR) is currently pointing at 0.05. The average price target for the stock over the next 12 months is $2.50, with the estimates having a low of $2.50 and a high of $2.50. These price ends are -400.0% and -400.0% off the today’s price level respectively, although investors could be excited at the prospect of a -400.0% if the OGEN share price touches on the median price of $2.50.

Coming back to Oragenics Inc. (AMEX:OGEN), we note that the average 3-month trading volume was 3.42 million, while that of the preceding 10-day period stands at 3.65 million. Current shares outstanding are 116.26 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

The insiders hold 0.20% of the company’s shares while institutions hold 9.20%. The data shows that short shares as of Dec 14, 2021, stood at 2.21 million at a short ratio of 1.1. This represents a 1.90% short interest in shares outstanding on Dec 14, 2021. Shares short fall in December from the previous month at 3.43 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 17.42% up in year-to-date price movement.